Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InMed Pharmaceuticals (INM) Research & Development: 2022-2025

Historic Research & Development for InMed Pharmaceuticals (INM) over the last 4 years, with Jun 2025 value amounting to $2.9 million.

  • InMed Pharmaceuticals' Research & Development fell 16.93% to $581,612 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 1.48%. This contributed to the annual value of $2.9 million for FY2025, which is 11.30% down from last year.
  • InMed Pharmaceuticals' Research & Development amounted to $2.9 million in FY2025, which was down 11.30% from $3.2 million recorded in FY2024.
  • In the past 5 years, InMed Pharmaceuticals' Research & Development ranged from a high of $7.3 million in FY2022 and a low of $2.9 million during FY2025.
  • Its 3-year average for Research & Development is $3.3 million, with a median of $3.2 million in 2024.
  • Data for InMed Pharmaceuticals' Research & Development shows a maximum YoY crashed of 48.75% (in 2023) over the last 5 years.
  • InMed Pharmaceuticals' Research & Development (Yearly) stood at $7.3 million in 2022, then slumped by 48.75% to $3.7 million in 2023, then fell by 13.79% to $3.2 million in 2024, then decreased by 11.30% to $2.9 million in 2025.